<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0417615</journal-id>
<journal-id journal-id-type="pubmed-jr-id">848</journal-id>
<journal-id journal-id-type="nlm-ta">Arch Toxicol</journal-id>
<journal-id journal-id-type="iso-abbrev">Arch. Toxicol.</journal-id>
<journal-title-group>
<journal-title>Archives of toxicology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0340-5761</issn>
<issn pub-type="epub">1432-0738</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31664499</article-id>
<article-id pub-id-type="pmc">7011178</article-id>
<article-id pub-id-type="doi">10.1007/s00204-019-02593-5</article-id>
<article-id pub-id-type="manuscript">NIHMS1068048</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Review of High-content Screening Applications in Toxicology</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Shuaizhang</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xia</surname>
<given-names>Menghang</given-names>
</name>
</contrib>
<aff id="A1">Division for Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA</aff>
</contrib-group>
<author-notes>
<corresp id="CR1"><label>*</label>Address correspondence to: Menghang Xia, Ph.D., National Institutes of Health, National Center for Advancing Translational Sciences, 9800 Medical Center Drive, Bethesda, MD 20892, Phone: 301-827-5359, <email>mxia@mail.nih.gov</email></corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P22">Declaration of Conflicting Interests</p>
<p id="P23">The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>27</day>
<month>1</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>29</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2020</year>
</pub-date>
<volume>93</volume>
<issue>12</issue>
<fpage>3387</fpage>
<lpage>3396</lpage>
<!--elocation-id from pubmed: 10.1007/s00204-019-02593-5-->
<abstract id="ABS1">
<p id="P1">High content screening (HCS) technology combining automated microscopy and quantitative image analysis can address biological questions in academia and the pharmaceutical industry. Various HCS experimental applications have been utilized in the research field of <italic>in vitro</italic> toxicology. In this review, we describe several HCS application approaches used for studying the mechanism of compound toxicity, highlight some challenges faced in the toxicological community, and discuss the future directions of HCS in regards to new models, new reagents, data management, and informatics. Many specialized areas of toxicology including developmental toxicity, genotoxicity, developmental neurotoxicity/neurotoxicity, hepatotoxicity, cardiotoxicity, and nephrotoxicity will be examined. In addition, several newly developed cellular assay models including induced pluripotent stem cells (iPSCs), three-dimensional (3D) cell models, and tissues-on-a-chip will be discussed. New genome editing technologies (e.g., CRISPR/Cas9), data analyzing tools for imaging, and coupling with high-content assays will be reviewed. Finally, the applications of machine learning to image processing will be explored. These new HCS approaches offer a huge step forward in dissecting biological processes, developing drugs, and making toxicology studies easier.</p>
</abstract>
<kwd-group>
<kwd>high-content screen</kwd>
<kwd>toxicology</kwd>
<kwd>HCS</kwd>
<kwd>Tox21</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>